Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_assertion type Assertion NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_head.
- NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_assertion description "[Our findings suggest further exploration of SIRT1 as a therapeutic target for CML treatment to overcome resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_provenance.
- NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_assertion evidence source_evidence_literature NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_provenance.
- NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_assertion SIO_000772 22207735 NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_provenance.
- NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_assertion wasDerivedFrom befree-2016 NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_provenance.
- NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_assertion wasGeneratedBy ECO_0000203 NP950002.RAHhlSmaoza0dcvELfPSCGYSndKOWJD-vg-FmDTu1fCxo130_provenance.